Approved Sample vs. Mass Production: What Buyers Still Need to Control

An approved sample is an important decision point, but it is often asked to carry more meaning than it can support. It proves that a particular result was achieved under a particular set of conditions. Unless those conditions are identified and transferred, the sample does not prove that the result will remain stable when the order moves into routine production.

The central buyer question is therefore not only, "Does this sample conform?" It is also, "Which material, process, tooling, inspection and external-provider conditions produced it—and how will those conditions be controlled after approval?"

The sample may have been made under exceptional conditions

Sample quantities are small. They may receive the most experienced operator, the preferred machine, additional manual fitting, repeated measurement or extra sorting. None of those actions is automatically improper during development. The risk appears when an exceptional method is not visible and cannot be repeated economically or consistently in production.

A dimensional report alone may not reveal this. The reported part can meet every measured value while the route behind it remains unsuitable for the planned quantity. Before approval, buyers should ask whether the sample used the intended production material, equipment, fixtures, program, outsourced processes and inspection method. If not, the difference should be recorded and closed through a production-representative trial.

Approve a baseline, not only a physical part

A stronger sample approval package links the accepted part with the information needed to reproduce it. The exact content depends on risk, but the baseline may include:

• drawing and specification revision;
• approved technical clarifications;
• material grade, condition and source status;
• manufacturing route and identified external processes;
• tooling, fixtures or key program revision;
• critical characteristics and inspection method;
• approved appearance reference where applicable;
• concessions or deviations and their expiry;
• packing and preservation requirements;
• changes that require notification or reapproval.

ASQ describes a quality plan as documentation that can identify standards, practices, resources, specifications, activity sequence, testing parameters, acceptance criteria, deliverables and required notifications for a product or contract. ASQ — Quality Plans The practical lesson is not that every small order needs a large formal package. It is that approval should preserve the conditions essential to repeat the result.

First article inspection is a production-transfer check

The phrase "first article" is used differently across industries. IAQG 9102 standardises FAI process and documentation requirements for aviation, space and defence products. IAQG also notes that the approach can be used in other sectors where a standardised FAI process is needed. IAQG — 9102 First Article Inspection Requirement

Outside a contractually specified standard, buyers should not claim that a particular FAI form is universally mandatory. They can still apply the underlying control logic: use a part from the intended production process to verify that the complete requirement has been understood and achieved before unrestricted production continues.

That normally requires more than checking a few critical dimensions. The review may need to confirm drawing accountability, material and process evidence, characteristic-level results, specified tests, approved deviations and the identity of the production route.

Define when production must pause

The first production batch is where economic and scheduling pressure becomes real. Material is purchased in production quantity, operators work to a normal cycle and external processors handle actual batches. This is the point at which hidden differences between the sample route and production route often become visible.

Buyers should therefore define a release gate. Depending on risk, the supplier may be required to produce the first units, complete agreed inspection, submit evidence and pause until approval. For lower-risk work, the gate may be a document review without a physical stop. For critical features or unproven processes, continuing the full batch before reviewing early evidence may make containment much more expensive.

The gate should answer four questions:

1. Which units or batch constitute the first production evidence?
2. Which characteristics and records must be reviewed?
3. Who has authority to release continued production?
4. What happens if the evidence does not meet the baseline?

Control changes that can invalidate approval

Approval loses value if the supplier can change the conditions behind it without review. Not every adjustment requires customer approval, but the parties should identify changes capable of affecting form, fit, function, appearance, reliability, compliance or traceability.

Typical triggers include a new material source or condition, a different production site, replacement tooling, a major program change, a different subcontractor, a revised heat-treatment or coating route, a change to the inspection method, a long interruption in production or a drawing revision.

The appropriate response may be notification, partial reinspection, a new first article or full requalification. The required response should reflect risk rather than applying the heaviest control to every change.

Do not let temporary deviations become the process

During sample and early production, buyers may accept a concession to protect schedule while a correction is completed. Such decisions need an identified part or batch, defined deviation, reason, approval authority and expiry condition.

Without those controls, a temporary deviation can quietly become the supplier's standard practice. Open corrective actions should therefore remain visible until implementation and effectiveness are confirmed. ASQ's description of the supplier corrective-action request process separates containment, root cause, implementation, effectiveness and closure—useful distinctions when a sample or early batch exposes a recurring risk. ASQ — Using the SCAR Document

A practical sample-to-production control sequence

1. Confirm the requirement baseline before the sample is made.
2. Record the actual route and conditions used for the approved sample.
3. Identify differences between sample conditions and planned production.
4. Close those differences through a production-representative run.
5. Define first-production inspection evidence and release authority.
6. Control material, process, site, tooling, subcontractor and inspection changes.
7. Track deviations and corrective actions to verified closure.
8. Retain an approved reference and records that can be used for repeat orders.

The approved sample remains useful. Its value increases when it is part of a controlled production baseline rather than the only evidence of readiness.

Buyer checklist

• Was the sample made to the current approved drawing and specification?
• Did it use production-intent material and material condition?
• Were production-intent equipment, tooling and fixtures used?
• Were external processes performed by the intended approved providers?
• Are critical characteristics and inspection methods agreed?
• Are any manual corrections or exceptional sorting steps recorded?
• What evidence must be approved before the full batch continues?
• Which changes trigger notification, reinspection or requalification?
• Are deviations limited to identified parts, batches and expiry conditions?
• Can the same baseline be retrieved for the next repeat order?